Studien

BoTULS

Botulinum Toxin for the Upper Limb after Stroke

BOULEVARD

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

BOX

Bart's-OXford study group

BOX

Blood Pressure and Oxygenation Targets after Out-of-Hospital Cardiac Arrest-trial

BOx-II

Brain Oxygenation in preterm infants

BOXIT

Bladder COX-2 Inhibition Trial

BP-CARE

Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries

BP-TARGET

Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

BPAV

Balloon Prophylaxis of Aneurysmal Vasospasm

BPEG

British Pacing and Electrophysiology Group study

BPLTTC

Blood Pressure Lowering Treatment Trialists’ Collaboration

BPMAP

Blood Pressure Management Application

BPROAD

Blood Pressure control target in Diabetes

BPSMC

Blood Pressure Study in Mexican Children

BRACE

BCG Vaccination to Protect Healthcare Workers Against COVID-19

BRACE-CORONA

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19

BRACELET

Bereavement and RAndomised ControlLEd Trials

BRACOVID

Genetic risk factors and COVID-19 severity in Brazil

BRAHMS

Methodology of the brodalumab assessment of hazards: a multicentre observational safety study

BRAIN

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases

BRAIN

Biomarker Rapid Assessment in Ischemic Injury

BRAIN-AF

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation

Brain-EXTEND

Exercise Effects on Brain Connectivity and Learning from Minutes to Months

BRAIN-GLULAC

Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury

BRAIN-ICU

Bringing to light the Risk factors and Incidence of Neuropsychological dysfunction in ICU survivors

BrainACT

Acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury

BrainGate2

Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

BRAINI

A Study of Biomarkers of Mild Traumatic BRAIN Injury

BRAINI-2 Elderly European

BRAINI-2 Elderly Mild TBI European Study

BRAINI-2 paediatric

Blood Biomarkers to Improve Management of Children With Traumatic Brain Injury

BRAINonFIT

Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors

BRAINS

Bayer Randomized Acute Ischemia Neuroprotectant Study

BRAINS

Blood flow Restriction training After patellar INStability

BRAIST

BRaicing in Adolescent Idiopathic Scoliosis Trial

BRANT

Efficacy and Safety of Tirofiban for Patients With BAD (Branch Atheromatous Disease)

BRASIL

Bleeding Risk Analysis in Stroke Imaging before thromboLysis

BRAVA

Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department

BRAVE

Bavarian Reperfusion Alternatives Evaluation

BRAVE

Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

BRAVE

Bonn Registry of Alternative anticoagulation to prevent Vascular Events

BRAVE

BReast cancer-Anemia and the Value of Erythropoietin study

BRAVE-2

Beyond 12 hours Reperfusion AlternatiVe Evaluation trial-2

BRAVE-3

Bavarian Reperfusion Alternatives Evaluation-3

BRAVE-AA1

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

BRAVE-AA2

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

BRAVEHeart

Breast Radiotherapy Audio Visual Enhancement for sparing the Heart

BRAVER

BRachial Artery Vascular Endothelium Reactivity

BRAVERY (EPOC1701)

A multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer

BRAVES

Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis

BRAVISSIMO

A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions

BRAVO

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

BRAVO

Blockade of the glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion

BRAVO

British Randomised Controlled Trial of Atrioventricular (AV) and Interventricular (VV) Optimisation

BRAVO

Brugada Ablation of VF Substrate Ongoing Multicenter Registry

BRAVO

Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent

BRAVO

RanibizumaB for the treatment of macular edema following BRAnch retinal Vein Occlusion-3

BRAVO I

Beta Radiation for treatment of ArterioVenous graft Outflow I

BRAVO-3

Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement

BRAVO-3MRI

Bivalirudin on Aortic Valve Intervention Outcomes-3

BRCT I

Brain Resuscitation Clinical Trial I